1 Study Coverage
    1.1 Pegfilgrastim Biosimilar Product Introduction
    1.2 Market by Type
        1.2.1 Global Pegfilgrastim Biosimilar Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Chemotherapy Treatment
        1.2.3 Transplantation
    1.3 Market by Application
        1.3.1 Global Pegfilgrastim Biosimilar Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Mail-Order Pharmacies
        1.3.4 Retail Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Pegfilgrastim Biosimilar Sales Estimates and Forecasts 2017-2028
    2.2 Global Pegfilgrastim Biosimilar Revenue Estimates and Forecasts 2017-2028
    2.3 Global Pegfilgrastim Biosimilar Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Pegfilgrastim Biosimilar Sales by Region
        2.4.1 Global Pegfilgrastim Biosimilar Sales by Region (2017-2022)
        2.4.2 Global Sales Pegfilgrastim Biosimilar by Region (2023-2028)
    2.5 Global Pegfilgrastim Biosimilar Revenue by Region
        2.5.1 Global Pegfilgrastim Biosimilar Revenue by Region (2017-2022)
        2.5.2 Global Pegfilgrastim Biosimilar Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Pegfilgrastim Biosimilar Sales by Manufacturers
        3.1.1 Global Top Pegfilgrastim Biosimilar Manufacturers by Sales (2017-2022)
        3.1.2 Global Pegfilgrastim Biosimilar Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pegfilgrastim Biosimilar in 2021
    3.2 Global Pegfilgrastim Biosimilar Revenue by Manufacturers
        3.2.1 Global Pegfilgrastim Biosimilar Revenue by Manufacturers (2017-2022)
        3.2.2 Global Pegfilgrastim Biosimilar Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Pegfilgrastim Biosimilar Revenue in 2021
    3.3 Global Pegfilgrastim Biosimilar Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Pegfilgrastim Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Pegfilgrastim Biosimilar Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Pegfilgrastim Biosimilar Sales by Type
        4.1.1 Global Pegfilgrastim Biosimilar Historical Sales by Type (2017-2022)
        4.1.2 Global Pegfilgrastim Biosimilar Forecasted Sales by Type (2023-2028)
        4.1.3 Global Pegfilgrastim Biosimilar Sales Market Share by Type (2017-2028)
    4.2 Global Pegfilgrastim Biosimilar Revenue by Type
        4.2.1 Global Pegfilgrastim Biosimilar Historical Revenue by Type (2017-2022)
        4.2.2 Global Pegfilgrastim Biosimilar Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Pegfilgrastim Biosimilar Revenue Market Share by Type (2017-2028)
    4.3 Global Pegfilgrastim Biosimilar Price by Type
        4.3.1 Global Pegfilgrastim Biosimilar Price by Type (2017-2022)
        4.3.2 Global Pegfilgrastim Biosimilar Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Pegfilgrastim Biosimilar Sales by Application
        5.1.1 Global Pegfilgrastim Biosimilar Historical Sales by Application (2017-2022)
        5.1.2 Global Pegfilgrastim Biosimilar Forecasted Sales by Application (2023-2028)
        5.1.3 Global Pegfilgrastim Biosimilar Sales Market Share by Application (2017-2028)
    5.2 Global Pegfilgrastim Biosimilar Revenue by Application
        5.2.1 Global Pegfilgrastim Biosimilar Historical Revenue by Application (2017-2022)
        5.2.2 Global Pegfilgrastim Biosimilar Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Pegfilgrastim Biosimilar Revenue Market Share by Application (2017-2028)
    5.3 Global Pegfilgrastim Biosimilar Price by Application
        5.3.1 Global Pegfilgrastim Biosimilar Price by Application (2017-2022)
        5.3.2 Global Pegfilgrastim Biosimilar Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Pegfilgrastim Biosimilar Market Size by Type
        6.1.1 North America Pegfilgrastim Biosimilar Sales by Type (2017-2028)
        6.1.2 North America Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
    6.2 North America Pegfilgrastim Biosimilar Market Size by Application
        6.2.1 North America Pegfilgrastim Biosimilar Sales by Application (2017-2028)
        6.2.2 North America Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
    6.3 North America Pegfilgrastim Biosimilar Market Size by Country
        6.3.1 North America Pegfilgrastim Biosimilar Sales by Country (2017-2028)
        6.3.2 North America Pegfilgrastim Biosimilar Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Pegfilgrastim Biosimilar Market Size by Type
        7.1.1 Europe Pegfilgrastim Biosimilar Sales by Type (2017-2028)
        7.1.2 Europe Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
    7.2 Europe Pegfilgrastim Biosimilar Market Size by Application
        7.2.1 Europe Pegfilgrastim Biosimilar Sales by Application (2017-2028)
        7.2.2 Europe Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
    7.3 Europe Pegfilgrastim Biosimilar Market Size by Country
        7.3.1 Europe Pegfilgrastim Biosimilar Sales by Country (2017-2028)
        7.3.2 Europe Pegfilgrastim Biosimilar Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Pegfilgrastim Biosimilar Market Size by Type
        8.1.1 Asia Pacific Pegfilgrastim Biosimilar Sales by Type (2017-2028)
        8.1.2 Asia Pacific Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
    8.2 Asia Pacific Pegfilgrastim Biosimilar Market Size by Application
        8.2.1 Asia Pacific Pegfilgrastim Biosimilar Sales by Application (2017-2028)
        8.2.2 Asia Pacific Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
    8.3 Asia Pacific Pegfilgrastim Biosimilar Market Size by Region
        8.3.1 Asia Pacific Pegfilgrastim Biosimilar Sales by Region (2017-2028)
        8.3.2 Asia Pacific Pegfilgrastim Biosimilar Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Pegfilgrastim Biosimilar Market Size by Type
        9.1.1 Latin America Pegfilgrastim Biosimilar Sales by Type (2017-2028)
        9.1.2 Latin America Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
    9.2 Latin America Pegfilgrastim Biosimilar Market Size by Application
        9.2.1 Latin America Pegfilgrastim Biosimilar Sales by Application (2017-2028)
        9.2.2 Latin America Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
    9.3 Latin America Pegfilgrastim Biosimilar Market Size by Country
        9.3.1 Latin America Pegfilgrastim Biosimilar Sales by Country (2017-2028)
        9.3.2 Latin America Pegfilgrastim Biosimilar Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Pegfilgrastim Biosimilar Market Size by Type
        10.1.1 Middle East and Africa Pegfilgrastim Biosimilar Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Pegfilgrastim Biosimilar Revenue by Type (2017-2028)
    10.2 Middle East and Africa Pegfilgrastim Biosimilar Market Size by Application
        10.2.1 Middle East and Africa Pegfilgrastim Biosimilar Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Pegfilgrastim Biosimilar Revenue by Application (2017-2028)
    10.3 Middle East and Africa Pegfilgrastim Biosimilar Market Size by Country
        10.3.1 Middle East and Africa Pegfilgrastim Biosimilar Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Pegfilgrastim Biosimilar Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novartis
        11.1.1 Novartis Corporation Information
        11.1.2 Novartis Overview
        11.1.3 Novartis Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novartis Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novartis Recent Developments
    11.2 Mylan
        11.2.1 Mylan Corporation Information
        11.2.2 Mylan Overview
        11.2.3 Mylan Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Mylan Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Mylan Recent Developments
    11.3 Coherus BioSciences
        11.3.1 Coherus BioSciences Corporation Information
        11.3.2 Coherus BioSciences Overview
        11.3.3 Coherus BioSciences Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Coherus BioSciences Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Coherus BioSciences Recent Developments
    11.4 Mundipharma International
        11.4.1 Mundipharma International Corporation Information
        11.4.2 Mundipharma International Overview
        11.4.3 Mundipharma International Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Mundipharma International Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Mundipharma International Recent Developments
    11.5 Biocon
        11.5.1 Biocon Corporation Information
        11.5.2 Biocon Overview
        11.5.3 Biocon Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Biocon Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Biocon Recent Developments
    11.6 Intas Pharmaceuticals
        11.6.1 Intas Pharmaceuticals Corporation Information
        11.6.2 Intas Pharmaceuticals Overview
        11.6.3 Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Intas Pharmaceuticals Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Intas Pharmaceuticals Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Corporation Information
        11.7.2 Pfizer Overview
        11.7.3 Pfizer Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Pfizer Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Pfizer Recent Developments
    11.8 Dr Reddy’s Laboratories
        11.8.1 Dr Reddy’s Laboratories Corporation Information
        11.8.2 Dr Reddy’s Laboratories Overview
        11.8.3 Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Dr Reddy’s Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Pegfilgrastim Biosimilar Industry Chain Analysis
    12.2 Pegfilgrastim Biosimilar Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Pegfilgrastim Biosimilar Production Mode & Process
    12.4 Pegfilgrastim Biosimilar Sales and Marketing
        12.4.1 Pegfilgrastim Biosimilar Sales Channels
        12.4.2 Pegfilgrastim Biosimilar Distributors
    12.5 Pegfilgrastim Biosimilar Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Pegfilgrastim Biosimilar Industry Trends
    13.2 Pegfilgrastim Biosimilar Market Drivers
    13.3 Pegfilgrastim Biosimilar Market Challenges
    13.4 Pegfilgrastim Biosimilar Market Restraints
14 Key Findings in The Global Pegfilgrastim Biosimilar Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Pegfilgrastim Biosimilar Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Chemotherapy Treatment
    Table 3. Major Manufacturers of Transplantation
    Table 4. Global Pegfilgrastim Biosimilar Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Pegfilgrastim Biosimilar Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Pegfilgrastim Biosimilar Sales by Region (2017-2022) & (K Units)
    Table 7. Global Pegfilgrastim Biosimilar Sales Market Share by Region (2017-2022)
    Table 8. Global Pegfilgrastim Biosimilar Sales by Region (2023-2028) & (K Units)
    Table 9. Global Pegfilgrastim Biosimilar Sales Market Share by Region (2023-2028)
    Table 10. Global Pegfilgrastim Biosimilar Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Pegfilgrastim Biosimilar Revenue Market Share by Region (2017-2022)
    Table 12. Global Pegfilgrastim Biosimilar Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Pegfilgrastim Biosimilar Revenue Market Share by Region (2023-2028)
    Table 14. Global Pegfilgrastim Biosimilar Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Pegfilgrastim Biosimilar Sales Share by Manufacturers (2017-2022)
    Table 16. Global Pegfilgrastim Biosimilar Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Pegfilgrastim Biosimilar Revenue Share by Manufacturers (2017-2022)
    Table 18. Pegfilgrastim Biosimilar Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Pegfilgrastim Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Pegfilgrastim Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pegfilgrastim Biosimilar as of 2021)
    Table 21. Pegfilgrastim Biosimilar Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Pegfilgrastim Biosimilar Product Offered
    Table 23. Date of Manufacturers Enter into Pegfilgrastim Biosimilar Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pegfilgrastim Biosimilar Sales by Type (2017-2022) & (K Units)
    Table 26. Global Pegfilgrastim Biosimilar Sales by Type (2023-2028) & (K Units)
    Table 27. Global Pegfilgrastim Biosimilar Sales Share by Type (2017-2022)
    Table 28. Global Pegfilgrastim Biosimilar Sales Share by Type (2023-2028)
    Table 29. Global Pegfilgrastim Biosimilar Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Pegfilgrastim Biosimilar Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Pegfilgrastim Biosimilar Revenue Share by Type (2017-2022)
    Table 32. Global Pegfilgrastim Biosimilar Revenue Share by Type (2023-2028)
    Table 33. Pegfilgrastim Biosimilar Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Pegfilgrastim Biosimilar Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Pegfilgrastim Biosimilar Sales by Application (2017-2022) & (K Units)
    Table 36. Global Pegfilgrastim Biosimilar Sales by Application (2023-2028) & (K Units)
    Table 37. Global Pegfilgrastim Biosimilar Sales Share by Application (2017-2022)
    Table 38. Global Pegfilgrastim Biosimilar Sales Share by Application (2023-2028)
    Table 39. Global Pegfilgrastim Biosimilar Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Pegfilgrastim Biosimilar Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Pegfilgrastim Biosimilar Revenue Share by Application (2017-2022)
    Table 42. Global Pegfilgrastim Biosimilar Revenue Share by Application (2023-2028)
    Table 43. Pegfilgrastim Biosimilar Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Pegfilgrastim Biosimilar Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Pegfilgrastim Biosimilar Sales by Type (2017-2022) & (K Units)
    Table 46. North America Pegfilgrastim Biosimilar Sales by Type (2023-2028) & (K Units)
    Table 47. North America Pegfilgrastim Biosimilar Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Pegfilgrastim Biosimilar Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Pegfilgrastim Biosimilar Sales by Application (2017-2022) & (K Units)
    Table 50. North America Pegfilgrastim Biosimilar Sales by Application (2023-2028) & (K Units)
    Table 51. North America Pegfilgrastim Biosimilar Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Pegfilgrastim Biosimilar Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Pegfilgrastim Biosimilar Sales by Country (2017-2022) & (K Units)
    Table 54. North America Pegfilgrastim Biosimilar Sales by Country (2023-2028) & (K Units)
    Table 55. North America Pegfilgrastim Biosimilar Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Pegfilgrastim Biosimilar Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Pegfilgrastim Biosimilar Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Pegfilgrastim Biosimilar Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Pegfilgrastim Biosimilar Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Pegfilgrastim Biosimilar Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Pegfilgrastim Biosimilar Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Pegfilgrastim Biosimilar Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Pegfilgrastim Biosimilar Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Pegfilgrastim Biosimilar Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Pegfilgrastim Biosimilar Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Pegfilgrastim Biosimilar Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Pegfilgrastim Biosimilar Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Pegfilgrastim Biosimilar Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Pegfilgrastim Biosimilar Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Pegfilgrastim Biosimilar Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Pegfilgrastim Biosimilar Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Pegfilgrastim Biosimilar Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Pegfilgrastim Biosimilar Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Pegfilgrastim Biosimilar Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Pegfilgrastim Biosimilar Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Pegfilgrastim Biosimilar Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Pegfilgrastim Biosimilar Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Pegfilgrastim Biosimilar Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Pegfilgrastim Biosimilar Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Pegfilgrastim Biosimilar Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Pegfilgrastim Biosimilar Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Pegfilgrastim Biosimilar Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Pegfilgrastim Biosimilar Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Pegfilgrastim Biosimilar Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Pegfilgrastim Biosimilar Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Pegfilgrastim Biosimilar Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Pegfilgrastim Biosimilar Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Pegfilgrastim Biosimilar Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Pegfilgrastim Biosimilar Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Pegfilgrastim Biosimilar Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Pegfilgrastim Biosimilar Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Pegfilgrastim Biosimilar Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Pegfilgrastim Biosimilar Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Pegfilgrastim Biosimilar Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Pegfilgrastim Biosimilar Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Pegfilgrastim Biosimilar Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Pegfilgrastim Biosimilar Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Pegfilgrastim Biosimilar Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Pegfilgrastim Biosimilar Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Pegfilgrastim Biosimilar Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Pegfilgrastim Biosimilar Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Pegfilgrastim Biosimilar Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Pegfilgrastim Biosimilar Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Pegfilgrastim Biosimilar Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Novartis Corporation Information
    Table 106. Novartis Description and Major Businesses
    Table 107. Novartis Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Novartis Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Novartis Recent Developments
    Table 110. Mylan Corporation Information
    Table 111. Mylan Description and Major Businesses
    Table 112. Mylan Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Mylan Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Mylan Recent Developments
    Table 115. Coherus BioSciences Corporation Information
    Table 116. Coherus BioSciences Description and Major Businesses
    Table 117. Coherus BioSciences Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Coherus BioSciences Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Coherus BioSciences Recent Developments
    Table 120. Mundipharma International Corporation Information
    Table 121. Mundipharma International Description and Major Businesses
    Table 122. Mundipharma International Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Mundipharma International Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Mundipharma International Recent Developments
    Table 125. Biocon Corporation Information
    Table 126. Biocon Description and Major Businesses
    Table 127. Biocon Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Biocon Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Biocon Recent Developments
    Table 130. Intas Pharmaceuticals Corporation Information
    Table 131. Intas Pharmaceuticals Description and Major Businesses
    Table 132. Intas Pharmaceuticals Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Intas Pharmaceuticals Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Intas Pharmaceuticals Recent Developments
    Table 135. Pfizer Corporation Information
    Table 136. Pfizer Description and Major Businesses
    Table 137. Pfizer Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Pfizer Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Pfizer Recent Developments
    Table 140. Dr Reddy’s Laboratories Corporation Information
    Table 141. Dr Reddy’s Laboratories Description and Major Businesses
    Table 142. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Dr Reddy’s Laboratories Pegfilgrastim Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Dr Reddy’s Laboratories Recent Developments
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Pegfilgrastim Biosimilar Distributors List
    Table 148. Pegfilgrastim Biosimilar Customers List
    Table 149. Pegfilgrastim Biosimilar Market Trends
    Table 150. Pegfilgrastim Biosimilar Market Drivers
    Table 151. Pegfilgrastim Biosimilar Market Challenges
    Table 152. Pegfilgrastim Biosimilar Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pegfilgrastim Biosimilar Product Picture
    Figure 3. Global Pegfilgrastim Biosimilar Market Share by Type in 2021 & 2028
    Figure 3. Chemotherapy Treatment Product Picture
    Figure 4. Transplantation Product Picture
    Figure 5. Global Pegfilgrastim Biosimilar Market Share by Application in 2021 & 2028
    Figure 6. Hospital Pharmacies
    Figure 7. Mail-Order Pharmacies
    Figure 8. Retail Pharmacies
    Figure 9. Pegfilgrastim Biosimilar Report Years Considered
    Figure 10. Global Pegfilgrastim Biosimilar Sales 2017-2028 (K Units)
    Figure 11. Global Pegfilgrastim Biosimilar Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Pegfilgrastim Biosimilar Revenue 2017-2028 (US$ Million)
    Figure 13. Global Pegfilgrastim Biosimilar Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Pegfilgrastim Biosimilar Sales Market Share by Region (2017-2022)
    Figure 15. Global Pegfilgrastim Biosimilar Sales Market Share by Region (2023-2028)
    Figure 16. North America Pegfilgrastim Biosimilar Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Pegfilgrastim Biosimilar Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Pegfilgrastim Biosimilar Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Pegfilgrastim Biosimilar Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Pegfilgrastim Biosimilar Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Pegfilgrastim Biosimilar Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Pegfilgrastim Biosimilar Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Pegfilgrastim Biosimilar Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Pegfilgrastim Biosimilar Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Pegfilgrastim Biosimilar Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Pegfilgrastim Biosimilar Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Pegfilgrastim Biosimilar in the World: Market Share by Pegfilgrastim Biosimilar Revenue in 2021
    Figure 28. Global Pegfilgrastim Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Pegfilgrastim Biosimilar Sales Market Share by Type (2017-2028)
    Figure 30. Global Pegfilgrastim Biosimilar Revenue Market Share by Type (2017-2028)
    Figure 31. Global Pegfilgrastim Biosimilar Sales Market Share by Application (2017-2028)
    Figure 32. Global Pegfilgrastim Biosimilar Revenue Market Share by Application (2017-2028)
    Figure 33. North America Pegfilgrastim Biosimilar Sales Market Share by Type (2017-2028)
    Figure 34. North America Pegfilgrastim Biosimilar Revenue Market Share by Type (2017-2028)
    Figure 35. North America Pegfilgrastim Biosimilar Sales Market Share by Application (2017-2028)
    Figure 36. North America Pegfilgrastim Biosimilar Revenue Market Share by Application (2017-2028)
    Figure 37. North America Pegfilgrastim Biosimilar Sales Share by Country (2017-2028)
    Figure 38. North America Pegfilgrastim Biosimilar Revenue Share by Country (2017-2028)
    Figure 39. United States Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Pegfilgrastim Biosimilar Sales Market Share by Type (2017-2028)
    Figure 42. Europe Pegfilgrastim Biosimilar Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Pegfilgrastim Biosimilar Sales Market Share by Application (2017-2028)
    Figure 44. Europe Pegfilgrastim Biosimilar Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Pegfilgrastim Biosimilar Sales Share by Country (2017-2028)
    Figure 46. Europe Pegfilgrastim Biosimilar Revenue Share by Country (2017-2028)
    Figure 47. Germany Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 48. France Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Pegfilgrastim Biosimilar Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Pegfilgrastim Biosimilar Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Pegfilgrastim Biosimilar Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Pegfilgrastim Biosimilar Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Pegfilgrastim Biosimilar Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Pegfilgrastim Biosimilar Revenue Share by Region (2017-2028)
    Figure 58. China Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 61. India Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Pegfilgrastim Biosimilar Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Pegfilgrastim Biosimilar Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Pegfilgrastim Biosimilar Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Pegfilgrastim Biosimilar Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Pegfilgrastim Biosimilar Sales Share by Country (2017-2028)
    Figure 72. Latin America Pegfilgrastim Biosimilar Revenue Share by Country (2017-2028)
    Figure 73. Mexico Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Pegfilgrastim Biosimilar Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Pegfilgrastim Biosimilar Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Pegfilgrastim Biosimilar Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Pegfilgrastim Biosimilar Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Pegfilgrastim Biosimilar Revenue Share by Country (2017-2028)
    Figure 82. Turkey Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Pegfilgrastim Biosimilar Revenue (2017-2028) & (US$ Million)
    Figure 85. Pegfilgrastim Biosimilar Value Chain
    Figure 86. Pegfilgrastim Biosimilar Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed